![Rob Slack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rob Slack
Director Técnico/Científico/I+D en
VICORE PHARMA HOLDING AB
.
Perfil
Rob Slack is currently Chief Scientific Officer at Vicore Pharma Holding AB since 2026.
Formerly, Dr. Slack was Vice President & Head-Respiratory Biology at GSK Plc and Chief Scientific Officer at Damora Therapeutics, Inc. Dr. Slack earned a doctorate from the University of Strathclyde.
Cargos activos de Rob Slack
| Empresas | Cargo | Inicio |
|---|---|---|
| VICORE PHARMA HOLDING AB | Director Técnico/Científico/I+D | 06/07/2026 |
Antiguos cargos conocidos de Rob Slack.
| Empresas | Cargo | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
| DAMORA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | - |
Formación de Rob Slack.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vicore Pharma Holding AB
 Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
- Bolsa de valores
- Insiders
- Rob Slack
Elige MarketScreener 
